NL8201321A - Werkwijze voor de behandeling van metastase en de groei van tumorcellen. - Google Patents
Werkwijze voor de behandeling van metastase en de groei van tumorcellen. Download PDFInfo
- Publication number
- NL8201321A NL8201321A NL8201321A NL8201321A NL8201321A NL 8201321 A NL8201321 A NL 8201321A NL 8201321 A NL8201321 A NL 8201321A NL 8201321 A NL8201321 A NL 8201321A NL 8201321 A NL8201321 A NL 8201321A
- Authority
- NL
- Netherlands
- Prior art keywords
- metastasis
- tumor cells
- cells
- tumor
- mice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25186481A | 1981-04-07 | 1981-04-07 | |
| US25186481 | 1981-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8201321A true NL8201321A (nl) | 1982-11-01 |
Family
ID=22953719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8201321A NL8201321A (nl) | 1981-04-07 | 1982-03-30 | Werkwijze voor de behandeling van metastase en de groei van tumorcellen. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0062319A1 (it) |
| JP (1) | JPS57179163A (it) |
| AU (1) | AU551063B2 (it) |
| BE (1) | BE892772A (it) |
| CA (1) | CA1265451A (it) |
| CH (1) | CH651753A5 (it) |
| DE (1) | DE3212068A1 (it) |
| ES (3) | ES8307753A1 (it) |
| FR (1) | FR2502954B1 (it) |
| GB (1) | GB2095997B (it) |
| GR (1) | GR75460B (it) |
| IL (1) | IL65423A (it) |
| IT (1) | IT1150790B (it) |
| NL (1) | NL8201321A (it) |
| NZ (1) | NZ200234A (it) |
| PH (1) | PH18651A (it) |
| ZA (1) | ZA822335B (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003027074A1 (en) * | 2001-09-25 | 2003-04-03 | Bayer Pharmaceuticals Corporation | Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2427272C3 (de) * | 1974-06-06 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum |
-
1982
- 1982-03-30 NL NL8201321A patent/NL8201321A/nl not_active Application Discontinuation
- 1982-03-31 CA CA000400261A patent/CA1265451A/en not_active Expired - Lifetime
- 1982-04-01 DE DE19823212068 patent/DE3212068A1/de not_active Withdrawn
- 1982-04-02 GB GB8209782A patent/GB2095997B/en not_active Expired
- 1982-04-02 EP EP82102800A patent/EP0062319A1/de not_active Withdrawn
- 1982-04-05 GR GR67819A patent/GR75460B/el unknown
- 1982-04-05 AU AU82353/82A patent/AU551063B2/en not_active Ceased
- 1982-04-05 NZ NZ200234A patent/NZ200234A/en unknown
- 1982-04-05 ZA ZA822335A patent/ZA822335B/xx unknown
- 1982-04-05 JP JP57055557A patent/JPS57179163A/ja active Pending
- 1982-04-05 IL IL65423A patent/IL65423A/xx unknown
- 1982-04-05 CH CH2133/82A patent/CH651753A5/de not_active IP Right Cessation
- 1982-04-06 IT IT20621/82A patent/IT1150790B/it active
- 1982-04-06 FR FR8205947A patent/FR2502954B1/fr not_active Expired
- 1982-04-06 PH PH27109A patent/PH18651A/en unknown
- 1982-04-06 ES ES511209A patent/ES8307753A1/es not_active Expired
- 1982-04-06 BE BE0/207764A patent/BE892772A/fr not_active IP Right Cessation
-
1983
- 1983-04-14 ES ES521457A patent/ES8404995A1/es not_active Expired
- 1983-04-14 ES ES521456A patent/ES521456A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57179163A (en) | 1982-11-04 |
| ES521457A0 (es) | 1984-05-16 |
| IT8220621A0 (it) | 1982-04-06 |
| FR2502954A1 (fr) | 1982-10-08 |
| ZA822335B (en) | 1983-03-30 |
| CH651753A5 (de) | 1985-10-15 |
| GB2095997A (en) | 1982-10-13 |
| CA1265451A (en) | 1990-02-06 |
| IT8220621A1 (it) | 1983-10-06 |
| ES511209A0 (es) | 1983-08-01 |
| ES8404995A1 (es) | 1984-05-16 |
| IL65423A (en) | 1984-12-31 |
| AU8235382A (en) | 1982-10-14 |
| NZ200234A (en) | 1985-07-12 |
| ES8404994A1 (es) | 1984-05-16 |
| ES8307753A1 (es) | 1983-08-01 |
| AU551063B2 (en) | 1986-04-17 |
| GR75460B (it) | 1984-07-20 |
| BE892772A (fr) | 1982-10-06 |
| DE3212068A1 (de) | 1982-11-18 |
| ES521456A0 (es) | 1984-05-16 |
| IL65423A0 (en) | 1982-07-30 |
| IT1150790B (it) | 1986-12-17 |
| GB2095997B (en) | 1986-01-22 |
| FR2502954B1 (fr) | 1985-10-25 |
| EP0062319A1 (de) | 1982-10-13 |
| PH18651A (en) | 1985-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Garbers et al. | A requirement of bicarbonate for Ca2+-induced elevations of cyclic AMP in guinea pig spermatozoa. | |
| EP3641819B1 (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| Leri et al. | Up-regulation of AT1 and AT2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death | |
| JP4047275B2 (ja) | ４−［（４−チアゾリル）フェノキシ］アルコキシ−ベンズアミジン誘導体の骨粗しょう症治療剤としての用途 | |
| US20160058797A1 (en) | Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries | |
| Zhang et al. | Effects of panax notoginseng saponins on homing of C-kit+ bone mesenchymal stem cells to the infarction heart in rats | |
| CN110876747A (zh) | 尿石素a在制备防治破骨细胞过度活化所致疾病药物中的应用 | |
| CA2006263A1 (en) | Sulfated tannins and their salts | |
| KR102014200B1 (ko) | 골질환의 예방 또는 치료용 의약 조성물 | |
| UA72913C2 (en) | Remedy for treating rheumatoid arthritis | |
| Wood Jr et al. | Host-parasite relationships in experimental pneumonia due to pneumococcus type III | |
| WO1999043326A1 (en) | Use of a cardiac purinoceptor to effect cellular glucose uptake | |
| CN113143913A (zh) | 一种桉烷型倍半萜类化合物在制备抗胰腺癌药物中的应用 | |
| CN104083761A (zh) | microRNA-101抑制剂在制备预防或治疗骨关节炎药物中的应用 | |
| NL8201321A (nl) | Werkwijze voor de behandeling van metastase en de groei van tumorcellen. | |
| JP2011516572A (ja) | アクチン細胞骨格再編成及び細胞間ギャップ形成調節の方法 | |
| Castor | Connective tissue activation. IV. Regulatory effects of antirheumatic drugs | |
| CN115252622A (zh) | 醛糖还原酶阻化剂及其在制备用于治疗肺癌的药物中的应用 | |
| CN107898785B (zh) | 氧化苦参碱在制备抗破骨细胞介导的骨丢失药物中的应用 | |
| CN113599396B (zh) | 天然化合物联合人间充质干细胞在制备治疗骨质疏松症药物中的应用 | |
| JPS5865224A (ja) | アテロ−ム性動脈硬化症の処置方法及び組成物 | |
| PT1682131E (pt) | Cci-779 para o tratamento do linfoma de células do manto | |
| CN113908148B (zh) | 川陈皮素在制备抗胆管癌药物中的应用 | |
| CN110974826B (zh) | 欧乌碱或12-表-欧乌碱在制备治疗白血病的药物中的应用 | |
| CN106902101A (zh) | 干巴菌素在制备抗肿瘤药物增敏剂中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BT | A notification was added to the application dossier and made available to the public | ||
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |